This opportunity has closed
The submission deadline was March 31, 2026. This page is kept for reference purposes.
6505--Venlafaxine 24HR Sustained Action Capsules
Actions
Create a free account to analyze this opportunity, get daily notifications, and win more bids with Narwin.ai
Documents
Additional Information
Source
Sam.gov
Type
RFP
Status
closed
Contract Type
Solicitation
Reference Number
36E79726R0010
Contact Name
Andrew J Cazares
Contact Email
Organization Province / State
IL
Organization Country
USA
Last Updated
April 1, 2026
Frequently Asked Questions
When is the proposal submission deadline?
The proposal submission deadline is March 31, 2026 (Overdue).
Note: This opportunity has already closed. See similar active opportunities above.
What NAICS codes apply to this opportunity?
The applicable NAICS codes are:
Where can I submit a proposal or get solicitation documents?
You can access the full solicitation documents and submit your proposal at the official source:
Visit Official SourceAdditional Details
NAICS Codes
Similar open opportunities 5 available
Since this opportunity has closed, here are similar active opportunities you may be interested in:
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
6505--Ramipril Capsules RFP
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
6505--FY27 Lenalidomide BPA
6505--INTENT TO SOLE SOURCE Radiopharm - Lutathera & Pluvicto - Lebanon VAMC
Explore More Opportunities
Open tenders from this agency
- 6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
RFP · Due November 17, 2026
- 6505--Ramipril Capsules RFP
RFP · Due November 23, 2026
- 6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
RFP · Due November 3, 2026
Historical Contracts
Research past opportunities
All Active Opportunities
Search all current contracts
Narwin.ai is a great way to find government contracts and opportunities. Disclaimer: This bid/tender/opportunity information is presented as is and may be incorrect at times. Please read the tender documents carefully before finalizing bids. We do not accept any responsibility and cannot be held legally liable for any inaccuracies.
